Health

Bharat Biotech Starts Exporting Covaxin; From December, More Countries Will Be Able To Get India-Made Jabs

As the number of countries that have obtained permission for Bharat Biotech’s COVID-19 vaccine, Covaxin, grows, the company stated that exports have begun.

Bharat Biotech said on Monday that exports of their COVID-19 vaccine, Covaxin, had begun. The Hyderabad-based biotech firm stated in a statement that long-awaited export orders for India-made Coronavirus vaccine “were implemented throughout November” and that it will be increased in the following months.

Read | COVID-19 Update: India Records 8,309 New Cases, 236 Deaths In Last 24 Hrs | Recovery Rate 98.3%

Exports to new countries will begin in December, according to the Indian biotech company, as the number of countries obtaining emergency use licences for Covaxin grows. Bharat Biotech also expressed its gratitude to the Indian government for approving exports. “Covaxin will now become a vital part of the global fight against this Pandemic,” the statement continued.

Bharat Biotech Vaccine
Bharat Biotech Vaccine

“Bharat Biotech has started exporting Covaxin,” the business says in a statement. Long-awaited export orders were fulfilled in November, with plans to grow in the coming months. Exports to new countries will begin in December as the number of nations that have given emergency use approvals for Covaxin grows.”

Bharat Biotech International Limited declared the start of Covaxin exports mere days after Dr Krishna Ella, Chairman and Managing Director of Bharat Biotech International Limited, released details about the vaccine’s manufacturing during the Republic India Economic Summit 2021. He claimed that producing the Coronavirus vaccine was a race against the virus rather than against other countries.

Read | DCGI Expert Panel Asks For More Data On Covovax | Approval Delayed In…

Ella was concerned about the safety of her coworkers while making Covaxin

With the onset of the pandemic, COVID-19 vaccinations, according to Ella, can be considered not only as a medical remedy for health care but also as a national security measure. He claimed that Chikungunya and Zika are less pathogenic than Coronavirus and other viruses on which Bharat Biotech has previously researched. Ella revealed during the Republic of India Economic Summit 2021 that working on the COVID-19 vaccine was worrisome because the disease is transferred directly and there is no vaccine to lessen the risks.

“The things that concerned the company during the voyage of manufacturing Covaxin were our staff,” Dr Ella continued, “can we produce this vaccine with the country’s prestige in mind, can we place science where the western world shouldn’t blame us as a country for being less science.”

Read | Jharkhand Health Minister has Appealed to PM Narendra Modi to stop all International Flights

Covaxin certificates from India are recognised in 110 countries

As of November 18, 110 countries recognise the certificates of India’s COIVID-18 vaccine, Covaxin, and Covishield, which are all made in the country. According to sources, more than a hundred countries have agreed to accept vaccination certificates from each other, including those that recognise Indian vaccination certificates for travellers who have been fully vaccinated with Covishield/WHO approved/nationally approved COVID vaccine.

Read | COVID-19 Update: India Records 8,309 New Cases, 236 Deaths In Last 24 Hrs | Recovery Rate 98.3%

Read | DCGI Expert Panel Asks For More Data On Covovax | Approval Delayed In…

Read | Jharkhand Health Minister has Appealed to PM Narendra Modi to stop all International Flights

Related Articles

Back to top button

Adblock Detected

Please close Adblocker